Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
-
Shares outstanding
-
9,036,176
-
Total 13F shares
-
15,781,393
-
Share change
-
+15,781,393
-
Total reported value
-
$426,251,845
-
Price per share
-
$27.01
-
Number of holders
-
47
-
Value change
-
+$426,251,845
-
Number of buys
-
47
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q2 2020
As of 30 Jun 2020,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,781,393 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, Casdin Capital, LLC, CANADA PENSION PLAN INVESTMENT BOARD, PRICE T ROWE ASSOCIATES INC /MD/, BAILLIE GIFFORD & CO, Hudson Bay Capital Management LP, JPMORGAN CHASE & CO, JENNISON ASSOCIATES LLC, and FMR LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.